Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03935399 · ClinicalTrials.gov registry record · Phase 4
Effects of Intramuscular Oxytocin on Sensory Function in Healthy Volunteers With Ultraviolet Burn Injury to the Skin
A Phase 4 study of Chronic Pain, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03935399: Completed Phase 4 study of Chronic Pain, sponsored by Wake Forest University Health Sciences.
NCT03935399 is a Phase 4 study of Chronic Pain that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 10 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03935399, a Phase 4 study of Chronic Pain, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This study proposes to evaluate the effects that a dose of oxytocin given by intramuscular (IM) injection (into the muscle) will have on an area of skin that has been exposed to ultraviolet (UV) light. The area of skin exposed to UV light will have a mild sun burn feeling. Sensory testing will be performed on the area of UV burn. The area will be evaluated for sensitivity in 3 methods: touch, vibratory
Primary Outcome
Vibration frequency detection threshold in the burned area after IM Oxytocin or placebo injection will be obtained by the subject placing the forearm area that was exposed to the UV burn on the oscillatory device and informing the investigators when the first perception of vibration is felt. A recording of the frequency (1 kilo Hertz to 1 Hertz) will be documented.
Conditions Studied
Interventions
- DRUG Saline
- DRUG Oxytocin
Study Locations (1)
North Carolina
- Wake Forest Baptist Health - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-08-08 |
| Est. Completion | 2020-04-30 |
| Phase | Phase 4 |
What the finished NCT03935399 record still lists
NCT03935399 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT03935399 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03935399 about?
NCT03935399 is a clinical study titled "Effects of Intramuscular Oxytocin on Sensory Function in Healthy Volunteers With Ultraviolet Burn Injury to the Skin". This study proposes to evaluate the effects that a dose of oxytocin given by intramuscular (IM) injection (into the muscle) will have on an area of skin that has been exposed to ultraviolet (UV) light. The area of skin exposed to UV light will have a mild sun burn feeling. Sensory testing will be p...
What is the current status of trial NCT03935399?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2019-08-08. Estimated completion is 2020-04-30.
What conditions does trial NCT03935399 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT03935399?
The interventions under investigation include: Saline (DRUG), Oxytocin (DRUG).
Who is sponsoring clinical trial NCT03935399?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03935399 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03935399's enrollment target sits among peer trials
10 292nd of 301 higher than 4 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NonNarcotic Pain Control in Percutaneous Needle Tenotomy of Elbow
RECRUITING · Phase 4
-
Stanford Pragmatic Effectiveness Comparison
RECRUITING · Phase 4
-
Better Options for Chronic Cancer Pain
RECRUITING · Phase 4
-
Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department
RECRUITING · Phase 4
-
Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment
ACTIVE NOT RECRUITING · Phase 4
-
Propofol-Enhanced Assessment of Ketamine for Chronic Pain and Depression
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI